Daratumumab Plus Bortezomib, Thalidomide, And Dexamethasone (D-Vtd) In Transplant-Eligible Newly Diagnosed Multiple Myeloma (Ndmm): Subgroup Analysis Of High-Risk Patients In Cassiopeia

Clinical Lymphoma Myeloma and Leukemia(2020)

引用 5|浏览67
暂无评分
关键词
daratumumab,Multiple myeloma,transplant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要